原发性和复发性质母细胞瘤对临床过程的影响的表观遗传特征
Alexander Quiring1, Hannah Spielmann2, Fritz Teping2
1Department of Neurosurgery, Klinikum Rechts Der Isar, Technical University Munich School of Medicine, 80333 Munich, Germany.
Biomedicines
|September 28, 2024
概括
质母细胞瘤 (GBM) 的表观遗传标记在疾病进展过程中往往不稳定. 像MGMT甲基化和miRNA表达等标记物的时间不稳定性可能会影响它们在质母细胞瘤的预后价值.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 癌症表观遗传学 癌症表观遗传学
背景情况:
- 质母细胞瘤 (GBM) 的预后越来越多地与表观遗传瘤特征有关.
- 这些表观遗传标记在疾病进展过程中的稳定性对于理解它们的预后可靠性至关重要.
研究的目的:
- 研究质母细胞瘤中关键表观遗传标记 (MGMT,p15,p16甲基化;miRNA-21, -24, -26a, -181d表达) 的时间稳定性.
- 为了确定疾病进展期间这些标记物的变化是否会影响它们的预后值.
主要方法:
- 对44名质母细胞瘤患者的原发性和复发性瘤样本的分析.
- 对MGMT的甲基化状态的评估,第15页和第16页.
- 对miRNA-21, -24, -26a和 -181d表达水平的评估.
- 表观遗传标记物稳定性与临床数据的相关性以及使用TCGA数据集的验证.
主要成果:
- 在所有检查的表观遗传标记物中观察到显著的不稳定性.
- 在30-37.5%的患者中,MGMT,p15和p16甲基化发生了变化.
- 微RNA的表达有所不同,一些患者表达稳定;在复发时,微RNA-21的减少与更长的存活时间相关.
- TCGA数据集验证了这些发现.
结论:
- 质母细胞瘤的表观遗传特征是动态的,在疾病进展过程中可以发生变化.
- 分子标记物的时间不稳定性可能会影响它们作为质母细胞瘤可靠预后指标的有用性.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...


